JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 34 No. 1 120-127
© 1993 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suehiro, M.
Right arrow Articles by Wagner, H. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suehiro, M.
Right arrow Articles by Wagner, H. N., Jr.

A PET Radiotracer for Studying Serotonin Uptake Sites: Carbon-11-McN-5652Z

Makiko Suehiro, Ursula Scheffel, Robert F. Dannals, Hayden T. Ravert, George A. Ricaurte and Henry N. Wagner, Jr.

Division of Nuclear Medicine and Radiation Health Sciences, The Johns Hopkins Medical Institutions, Baltimore, Maryland

Correspondence: For reprints correspondence contact: Ursula Scheffel, Division of Nuclear Medicine and Radiation Health Sciences, The Johns Hopkins Medical Institutions, 615 North Wolfe St., Baltimore, MD 21205-2179.

ABSTRACT

A radioligand for imaging central serotonin (5-hydroxytryptamine; 5-HT) uptake sites by positron emission tomography (PET) has yet to be developed. Such a tracer would be useful for the study of normal and altered serotonergic neurotransmission as well as for the detection of serotonergic neurotoxicity. This paper describes the labeling of the highly potent serotonin (5-HT) uptake blocker, McN-5652-Z (trans-1,2,3,5,6,10ß-hexahydro-6-[4-(methylthio)phenyl]pyrrolo[2,1-a]-isoquinoline; racemic mixture), with 11C and the evaluation of this radiotracer in rodents with respect to its in vivo binding characteristics. In mouse brain, 11C-McN-5652-Z accumulated rapidly in regions with high densities of 5-HT uptake sites. The ratio between hypothalamus and cerebellum was 1.5:1 at 15 min and increased with time to 4.6:1 at 90 min after injection. The distribution of 11C-McN-5652 in rat brain at 60 min correlated well with regional concentrations of 5-HT uptake sites (r = 0.86). The specificity and selectivity of 11C-McN-5652 binding to the 5-HT transporter were tested by preinjecting blocking doses of known 5-HT, dopamine and norepinephrine uptake inhibitors, and a 5-HT2 receptor blocker before injection of the radiotracer. Preinjection of increasing doses of unlabeled McN-5652-Z inhibited 11C-McN 5652-Z binding in a dose-dependent fashion. These results suggest that the in vivo binding of the radiotracer was specific, selective for 5-HT uptake sites, saturable and that 11C-McN-5652-Z holds promise as a radiotracer for PET imaging of 5-HT uptake sites in the mammalian brain.




This article has been cited by other articles:


Home page
JNMHome page
M. Slifstein
Revisiting an Old Issue: The Discrepancy Between Tissue Ratio-Derived Binding Parameters and Kinetic Modeling-Derived Parameters After a Bolus of the Serotonin Transporter Radioligand 123I-ADAM
J. Nucl. Med., February 1, 2008; 49(2): 176 - 178.
[Full Text] [PDF]


Home page
JNMHome page
A. B. Newberg, J. D. Amsterdam, N. Wintering, K. Ploessl, R. L. Swanson, J. Shults, and A. Alavi
123I-ADAM Binding to Serotonin Transporters in Patients with Major Depression and Healthy Controls: A Preliminary Study
J. Nucl. Med., June 1, 2005; 46(6): 973 - 977.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. B. Newberg, K. Plossl, P. D. Mozley, J. B. Stubbs, N. Wintering, M. Udeshi, A. Alavi, T. Kauppinen, and H. F. Kung
Biodistribution and Imaging with 123I-ADAM: A Serotonin Transporter Imaging Agent
J. Nucl. Med., May 1, 2004; 45(5): 834 - 841.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
B. Bolon
Comparative and Correlative Neuroanatomy for the Toxicologic Pathologist
Toxicol Pathol, January 1, 2000; 28(1): 6 - 27.
[Abstract] [PDF]


Home page
Pharmacol. Rev.Home page
G. Pineyro and P. Blier
Autoregulation of Serotonin Neurons: Role in Antidepressant Drug Action
Pharmacol. Rev., September 1, 1999; 51(3): 533 - 591.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1993 by the Society of Nuclear Medicine.